Literature DB >> 19193910

Presentation of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop.

Shonni J Silverberg1, E Michael Lewiecki, Leif Mosekilde, Munro Peacock, Mishaela R Rubin.   

Abstract

BACKGROUND: At the Third International Workshop on Asymptomatic Primary Hyperparathyroidism (PHPT) in May 2008, recent data on the disease were reviewed. We present the results of a literature review on issues arising from the clinical presentation and natural history of PHPT.
METHODS: Questions were developed by the International Task Force on PHPT. A comprehensive literature search for relevant studies was reviewed, and the questions of the International Task Force were addressed by the Consensus Panel.
CONCLUSIONS: 1) Data on the extent and nature of cardiovascular involvement in those with mild disease are too limited to provide a complete picture. 2) Patients with mild PHPT have neuropsychological complaints. Although some symptoms may improve with surgery, available data remain inconsistent on their precise nature and reversibility. 3) Surgery leads to long-term gains in spine, hip, and radius bone mineral density (BMD). Because some patients have early disease progression and others lose BMD after 8-10 yr, regular monitoring (serum calcium and three-site BMD) is essential in those followed without surgery. Patients may present with normocalcemic PHPT (normal serum calcium with elevated PTH concentrations; no secondary cause for hyperparathyroidism). Data on the incidence and natural history of this phenotype are limited. 4) In the absence of kidney stones, data do not support the use of marked hypercalciuria (>10 mmol/d or 400 mg/d) as an indication for surgery for patients. 5) Patients with bone density T-score -2.5 or less at the lumbar spine, hip, or distal one third radius should have surgery.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19193910      PMCID: PMC5393372          DOI: 10.1210/jc.2008-1760

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  102 in total

1.  Parathyroidectomy improves neurocognitive deficits in patients with primary hyperparathyroidism.

Authors:  Sanziana A Roman; Julie Ann Sosa; Linda Mayes; Eric Desmond; Leon Boudourakis; Rong Lin; Peter J Snyder; Elizabeth Holt; Robert Udelsman
Journal:  Surgery       Date:  2005-12       Impact factor: 3.982

2.  Left ventricular hypertrophy in primary hyperparathyroidism. Effects of successful parathyroidectomy.

Authors:  A Piovesan; N Molineri; F Casasso; I Emmolo; G Ugliengo; F Cesario; G Borretta
Journal:  Clin Endocrinol (Oxf)       Date:  1999-03       Impact factor: 3.478

3.  Patient-based surgical outcome tool demonstrating alleviation of symptoms following parathyroidectomy in patients with primary hyperparathyroidism.

Authors:  Janice L Pasieka; Louise L Parsons; Michael J Demeure; Stuart Wilson; Peter Malycha; Jean Jones; Beth Krzywda
Journal:  World J Surg       Date:  2002-05-21       Impact factor: 3.352

4.  Causes of death in patients previously operated on for primary hyperparathyroidism.

Authors:  H Ronni-Sivula
Journal:  Ann Chir Gynaecol       Date:  1985

5.  Medical observation, compared with parathyroidectomy, for asymptomatic primary hyperparathyroidism: a prospective, randomized trial.

Authors:  Jens Bollerslev; Svante Jansson; Charlotte L Mollerup; Jörgen Nordenström; Eva Lundgren; Ove Tørring; Jan-Erik Varhaug; Marek Baranowski; Sylvi Aanderud; Celina Franco; Bo Freyschuss; Gunhild A Isaksen; Thor Ueland; Thord Rosen
Journal:  J Clin Endocrinol Metab       Date:  2007-02-06       Impact factor: 5.958

6.  Primary hyperparathyroidism: incidence of cardiac abnormalities and partial reversibility after successful parathyroidectomy.

Authors:  T Stefenelli; H Mayr; J Bergler-Klein; S Globits; W Woloszczuk; B Niederle
Journal:  Am J Med       Date:  1993-08       Impact factor: 4.965

7.  Cardiac dysfunction in mild primary hyperparathyroidism assessed by radionuclide angiography and echocardiography before and after parathyroidectomy.

Authors:  Erik G Almqvist; Anne-Greth Bondeson; Lennart Bondeson; Anders Nissborg; Peter Smedgård; Sven-Eric Svensson
Journal:  Surgery       Date:  2002-12       Impact factor: 3.982

8.  Neuropsychologic deficits associated with primary hyperparathyroidism.

Authors:  P J Numann; A J Torppa; A E Blumetti
Journal:  Surgery       Date:  1984-12       Impact factor: 3.982

9.  Serum parathyroid hormone levels predict coronary heart disease: the Tromsø Study.

Authors:  Elena Kamycheva; Johan Sundsfjord; Rolf Jorde
Journal:  Eur J Cardiovasc Prev Rehabil       Date:  2004-02

10.  Remarkable increase in lumbar spine bone mineral density and amelioration in biochemical markers of bone turnover after parathyroidectomy in elderly patients with primary hyperparathyroidism: a 5-year follow-up study.

Authors:  Yoshiaki Tamura; Atsushi Araki; Yuko Chiba; Seijiro Mori; Takayuki Hosoi; Toshiyuki Horiuchi
Journal:  J Bone Miner Metab       Date:  2007-06-25       Impact factor: 2.976

View more
  78 in total

1.  Effect of parathyroidectomy on subclinical cardiovascular disease in mild primary hyperparathyroidism.

Authors:  M D Walker; T Rundek; S Homma; M DiTullio; S Iwata; J A Lee; J Choi; R Liu; C Zhang; D J McMahon; R L Sacco; S J Silverberg
Journal:  Eur J Endocrinol       Date:  2012-06-01       Impact factor: 6.664

2.  Evaluation of selected cognitive functions before and after surgery for primary hyperparathyroidism.

Authors:  Dominika Babińska; Marcin Barczyński; Tomasz Stefaniak; Tomasz Osęka; Anna Babińska; Dariusz Babiński; Krzysztof Sworczak; Andrzej J Lachiński; Wojciech Nowak; Zbigniew Sledziński
Journal:  Langenbecks Arch Surg       Date:  2011-12-08       Impact factor: 3.445

3.  Bone: Is screening for secondary causes of osteoporosis worthwhile?

Authors:  J Chris Gallagher; Adarsh J Sai
Journal:  Nat Rev Endocrinol       Date:  2010-07       Impact factor: 43.330

4.  Hyperparathyroidism, an emerging disease.

Authors:  Guido Gasparri; Nicola Palestini; Silvia Catalano; Francesca Talarico; Clemente Ronchetta; Gregorio Balbo; Michele Camandona
Journal:  Updates Surg       Date:  2010-11-13

Review 5.  Clinical aspects of primary hyperparathyroidism: clinical manifestations, diagnosis, and therapy.

Authors:  Rudolf Wolfgang Gasser
Journal:  Wien Med Wochenschr       Date:  2013-08-29

6.  Primary Hyperparathyroidism: A Tale of Two Cities Revisited - New York and Shanghai.

Authors:  Jian-Min Liu; Natalie E Cusano; Barbara C Silva; Lin Zhao; Xiao-Yan He; Bei Tao; Li-Hao Sun; Hong-Yan Zhao; Wen-Wei Fan; Megan E Romano; Guang Ning; John P Bilezikian
Journal:  Bone Res       Date:  2013-06-28       Impact factor: 13.567

7.  Surgical management of normocalcemic primary hyperparathyroidism.

Authors:  Thomas J Wade; Tina W F Yen; Amanda L Amin; Tracy S Wang
Journal:  World J Surg       Date:  2012-04       Impact factor: 3.352

8.  Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop.

Authors:  John P Bilezikian; Aliya A Khan; John T Potts
Journal:  J Clin Endocrinol Metab       Date:  2009-02       Impact factor: 5.958

9.  Normocalcemic primary hyperparathyroidism: one-year follow-up in one hundred postmenopausal women.

Authors:  Antonia García-Martín; Rebeca Reyes-García; Manuel Muñoz-Torres
Journal:  Endocrine       Date:  2012-12       Impact factor: 3.633

10.  Cardiovascular risk and metabolic syndrome in primary hyperparathyroidism and their correlation to different clinical forms.

Authors:  M Procopio; M Barale; S Bertaina; S Sigrist; R Mazzetti; M Loiacono; G Mengozzi; E Ghigo; M Maccario
Journal:  Endocrine       Date:  2013-11-28       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.